Energy and caloric restriction, and fasting and cancer: a narrative review

go back to reference De Pergola G, Silvestris F (2013) Obesity as a major risk factor for cancer. J Obes 291546:1–11. https://doi.org/10.1155/2013/291546CrossRef De Pergola G, Silvestris F (2013) Obesity as a major risk factor for cancer. J Obes 291546:1–11. https://​doi.​org/​10.​1155/​2013/​291546CrossRef

go back to reference Demark-Wahnefried W, Platz EA, Ligibel JA, Blair CK, Courneya KS, Meyerhardt JA, Ganz PA, Rock CL, Schmitz KH, Wadden T, Philip EJ, Wolfe B, Gapstur SM, Ballard-Barbash R, McTiernan A, Minasian L, Nebeling L, Goodwin PJ (2012) The role of obesity in cancer survival and recurrence. Cancer Epidemiol Biomark Prev 21:1244–1259. https://doi.org/10.1158/1055-9965.EPI-12-0485CrossRef Demark-Wahnefried W, Platz EA, Ligibel JA, Blair CK, Courneya KS, Meyerhardt JA, Ganz PA, Rock CL, Schmitz KH, Wadden T, Philip EJ, Wolfe B, Gapstur SM, Ballard-Barbash R, McTiernan A, Minasian L, Nebeling L, Goodwin PJ (2012) The role of obesity in cancer survival and recurrence. Cancer Epidemiol Biomark Prev 21:1244–1259. https://​doi.​org/​10.​1158/​1055-9965.​EPI-12-0485CrossRef

go back to reference Lee C, Raffaghello L, Brandhorst S et al (2012) Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy. Sci Transl Med 4:124ra27. https://doi.org/10.1126/scitranslmed.3003293CrossRefPubMedPubMedCentral Lee C, Raffaghello L, Brandhorst S et al (2012) Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy. Sci Transl Med 4:124ra27. https://​doi.​org/​10.​1126/​scitranslmed.​3003293CrossRefPubMedPubMedCentral

go back to reference Galluzzi L, Baehrecke EH, Ballabio A et al (2017) Molecular definitions of autophagy and related processes. EMBO J 36:1811–1836. https://doi.org/10.15252/embj.201796697CrossRefPubMedPubMedCentral Galluzzi L, Baehrecke EH, Ballabio A et al (2017) Molecular definitions of autophagy and related processes. EMBO J 36:1811–1836. https://​doi.​org/​10.​15252/​embj.​201796697CrossRefPubMedPubMedCentral

go back to reference Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, Annicchiarico-Petruzzelli M, Antonov AV, Arama E, Baehrecke EH, Barlev NA, Bazan NG, Bernassola F, Bertrand MJM, Bianchi K, Blagosklonny MV, Blomgren K, Borner C, Boya P, Brenner C, Campanella M, Candi E, Carmona-Gutierrez D, Cecconi F, Chan FKM, Chandel NS, Cheng EH, Chipuk JE, Cidlowski JA, Ciechanover A, Cohen GM, Conrad M, Cubillos-Ruiz JR, Czabotar PE, D’Angiolella V, Dawson TM, Dawson VL, de Laurenzi V, de Maria R, Debatin KM, DeBerardinis RJ, Deshmukh M, di Daniele N, di Virgilio F, Dixit VM, Dixon SJ, Duckett CS, Dynlacht BD, el-Deiry WS, Elrod JW, Fimia GM, Fulda S, García-Sáez AJ, Garg AD, Garrido C, Gavathiotis E, Golstein P, Gottlieb E, Green DR, Greene LA, Gronemeyer H, Gross A, Hajnoczky G, Hardwick JM, Harris IS, Hengartner MO, Hetz C, Ichijo H, Jäättelä M, Joseph B, Jost PJ, Juin PP, Kaiser WJ, Karin M, Kaufmann T, Kepp O, Kimchi A, Kitsis RN, Klionsky DJ, Knight RA, Kumar S, Lee SW, Lemasters JJ, Levine B, Linkermann A, Lipton SA, Lockshin RA, López-Otín C, Lowe SW, Luedde T, Lugli E, MacFarlane M, Madeo F, Malewicz M, Malorni W, Manic G, Marine JC, Martin SJ, Martinou JC, Medema JP, Mehlen P, Meier P, Melino S, Miao EA, Molkentin JD, Moll UM, Muñoz-Pinedo C, Nagata S, Nuñez G, Oberst A, Oren M, Overholtzer M, Pagano M, Panaretakis T, Pasparakis M, Penninger JM, Pereira DM, Pervaiz S, Peter ME, Piacentini M, Pinton P, Prehn JHM, Puthalakath H, Rabinovich GA, Rehm M, Rizzuto R, Rodrigues CMP, Rubinsztein DC, Rudel T, Ryan KM, Sayan E, Scorrano L, Shao F, Shi Y, Silke J, Simon HU, Sistigu A, Stockwell BR, Strasser A, Szabadkai G, Tait SWG, Tang D, Tavernarakis N, Thorburn A, Tsujimoto Y, Turk B, vanden Berghe T, Vandenabeele P, Vander Heiden MG, Villunger A, Virgin HW, Vousden KH, Vucic D, Wagner EF, Walczak H, Wallach D, Wang Y, Wells JA, Wood W, Yuan J, Zakeri Z, Zhivotovsky B, Zitvogel L, Melino G, Kroemer G (2018) Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ 25:486–541. https://doi.org/10.1038/s41418-017-0012-4CrossRefPubMedPubMedCentral Galluzzi L, Vitale I, Aaronson SA, Abrams JM, Adam D, Agostinis P, Alnemri ES, Altucci L, Amelio I, Andrews DW, Annicchiarico-Petruzzelli M, Antonov AV, Arama E, Baehrecke EH, Barlev NA, Bazan NG, Bernassola F, Bertrand MJM, Bianchi K, Blagosklonny MV, Blomgren K, Borner C, Boya P, Brenner C, Campanella M, Candi E, Carmona-Gutierrez D, Cecconi F, Chan FKM, Chandel NS, Cheng EH, Chipuk JE, Cidlowski JA, Ciechanover A, Cohen GM, Conrad M, Cubillos-Ruiz JR, Czabotar PE, D’Angiolella V, Dawson TM, Dawson VL, de Laurenzi V, de Maria R, Debatin KM, DeBerardinis RJ, Deshmukh M, di Daniele N, di Virgilio F, Dixit VM, Dixon SJ, Duckett CS, Dynlacht BD, el-Deiry WS, Elrod JW, Fimia GM, Fulda S, García-Sáez AJ, Garg AD, Garrido C, Gavathiotis E, Golstein P, Gottlieb E, Green DR, Greene LA, Gronemeyer H, Gross A, Hajnoczky G, Hardwick JM, Harris IS, Hengartner MO, Hetz C, Ichijo H, Jäättelä M, Joseph B, Jost PJ, Juin PP, Kaiser WJ, Karin M, Kaufmann T, Kepp O, Kimchi A, Kitsis RN, Klionsky DJ, Knight RA, Kumar S, Lee SW, Lemasters JJ, Levine B, Linkermann A, Lipton SA, Lockshin RA, López-Otín C, Lowe SW, Luedde T, Lugli E, MacFarlane M, Madeo F, Malewicz M, Malorni W, Manic G, Marine JC, Martin SJ, Martinou JC, Medema JP, Mehlen P, Meier P, Melino S, Miao EA, Molkentin JD, Moll UM, Muñoz-Pinedo C, Nagata S, Nuñez G, Oberst A, Oren M, Overholtzer M, Pagano M, Panaretakis T, Pasparakis M, Penninger JM, Pereira DM, Pervaiz S, Peter ME, Piacentini M, Pinton P, Prehn JHM, Puthalakath H, Rabinovich GA, Rehm M, Rizzuto R, Rodrigues CMP, Rubinsztein DC, Rudel T, Ryan KM, Sayan E, Scorrano L, Shao F, Shi Y, Silke J, Simon HU, Sistigu A, Stockwell BR, Strasser A, Szabadkai G, Tait SWG, Tang D, Tavernarakis N, Thorburn A, Tsujimoto Y, Turk B, vanden Berghe T, Vandenabeele P, Vander Heiden MG, Villunger A, Virgin HW, Vousden KH, Vucic D, Wagner EF, Walczak H, Wallach D, Wang Y, Wells JA, Wood W, Yuan J, Zakeri Z, Zhivotovsky B, Zitvogel L, Melino G, Kroemer G (2018) Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ 25:486–541. https://​doi.​org/​10.​1038/​s41418-017-0012-4CrossRefPubMedPubMedCentral

go back to reference Kimmelman AC, White E (2017) Autophagy and tumor metabolism. Cell Metab 25:1037–1043. https://doi.org/10.1016/j.cmet.2017.04.004CrossRefPubMedPubMedCentral Kimmelman AC, White E (2017) Autophagy and tumor metabolism. Cell Metab 25:1037–1043. https://​doi.​org/​10.​1016/​j.​cmet.​2017.​04.​004CrossRefPubMedPubMedCentral

go back to reference Kroemer G, Mariño G, Levine B (2010) Autophagy and the integrated stress response. Mol Cell 40:280–293. https://doi.org/10.1016/j.molcel.2010.09.023CrossRefPubMedPubMedCentral Kroemer G, Mariño G, Levine B (2010) Autophagy and the integrated stress response. Mol Cell 40:280–293. https://​doi.​org/​10.​1016/​j.​molcel.​2010.​09.​023CrossRefPubMedPubMedCentral

go back to reference Galluzzi L, Pietrocola F, Bravo-San Pedro JM et al (2015) Autophagy in malignant transformation and cancer progression. EMBO J 34:856–880. https://doi.org/10.15252/embj.201490784CrossRefPubMedPubMedCentral Galluzzi L, Pietrocola F, Bravo-San Pedro JM et al (2015) Autophagy in malignant transformation and cancer progression. EMBO J 34:856–880. https://​doi.​org/​10.​15252/​embj.​201490784CrossRefPubMedPubMedCentral

go back to reference Sharifi MN, Mowers EE, Drake LE, Collier C, Chen H, Zamora M, Mui S, Macleod KF (2016) Autophagy promotes focal adhesion disassembly and cell motility of metastatic tumor cells through the direct interaction of Paxillin with LC3. Cell Rep 15:1660–1672. https://doi.org/10.1016/j.celrep.2016.04.065CrossRefPubMedPubMedCentral Sharifi MN, Mowers EE, Drake LE, Collier C, Chen H, Zamora M, Mui S, Macleod KF (2016) Autophagy promotes focal adhesion disassembly and cell motility of metastatic tumor cells through the direct interaction of Paxillin with LC3. Cell Rep 15:1660–1672. https://​doi.​org/​10.​1016/​j.​celrep.​2016.​04.​065CrossRefPubMedPubMedCentral

go back to reference Lebovitz CB, Robertson AG, Goya R, Jones SJ, Morin RD, Marra MA, Gorski SM (2015) Cross-cancer profiling of molecular alterations within the human autophagy interaction network. Autophagy 11:1668–1687. https://doi.org/10.1080/15548627.2015.1067362CrossRefPubMedPubMedCentral Lebovitz CB, Robertson AG, Goya R, Jones SJ, Morin RD, Marra MA, Gorski SM (2015) Cross-cancer profiling of molecular alterations within the human autophagy interaction network. Autophagy 11:1668–1687. https://​doi.​org/​10.​1080/​15548627.​2015.​1067362CrossRefPubMedPubMedCentral

go back to reference Mrakovcic M, Fröhlich LF (2018) p53-mediated molecular control of autophagy in tumor cells. Biomolecules 8:14. https://doi.org/10.3390/biom8020014CrossRefPubMedCentral Mrakovcic M, Fröhlich LF (2018) p53-mediated molecular control of autophagy in tumor cells. Biomolecules 8:14. https://​doi.​org/​10.​3390/​biom8020014CrossRefPubMedCentral

go back to reference Chen N, Karantza V (2011) Autophagy as a therapeutic target in cancer. Cancer Biol Ther 11:157–168. https://doi.org/10.4161/cbt.11.2.14622CrossRefPubMedPubMedCentral Chen N, Karantza V (2011) Autophagy as a therapeutic target in cancer. Cancer Biol Ther 11:157–168. https://​doi.​org/​10.​4161/​cbt.​11.​2.​14622CrossRefPubMedPubMedCentral

go back to reference Galluzzi L, Bravo-San Pedro JM, Levine B, Green DR, Kroemer G (2017) Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles. Nat Rev Drug Discov 16:487–511. https://doi.org/10.1038/nrd.2017.22CrossRefPubMedPubMedCentral Galluzzi L, Bravo-San Pedro JM, Levine B, Green DR, Kroemer G (2017) Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles. Nat Rev Drug Discov 16:487–511. https://​doi.​org/​10.​1038/​nrd.​2017.​22CrossRefPubMedPubMedCentral

go back to reference Fulda S, Kögel D (2015) Cell death by autophagy: emerging molecular mechanisms and implications for cancer therapy. Oncogene 34:5105–5113. https://doi.org/10.1038/onc.2014.458CrossRefPubMed Fulda S, Kögel D (2015) Cell death by autophagy: emerging molecular mechanisms and implications for cancer therapy. Oncogene 34:5105–5113. https://​doi.​org/​10.​1038/​onc.​2014.​458CrossRefPubMed

go back to reference Fulda S (2017) Autophagy in cancer therapy. Front Oncol 7:128. https://doi.org/10.3389/fonc.2017.00128CrossRefPubMedPubMedCentral Fulda S (2017) Autophagy in cancer therapy. Front Oncol 7:128. https://​doi.​org/​10.​3389/​fonc.​2017.​00128CrossRefPubMedPubMedCentral

go back to reference Grasso S, Pereira GJS, Palmeira-Dos-Santos C et al (2016) Autophagy regulates Selumetinib (AZD6244) induced-apoptosis in colorectal cancer cells. Eur J Med Chem 122:611–618. https://doi.org/10.1016/j.ejmech.2016.06.043CrossRefPubMed Grasso S, Pereira GJS, Palmeira-Dos-Santos C et al (2016) Autophagy regulates Selumetinib (AZD6244) induced-apoptosis in colorectal cancer cells. Eur J Med Chem 122:611–618. https://​doi.​org/​10.​1016/​j.​ejmech.​2016.​06.​043CrossRefPubMed

go back to reference Palmeira dos Santos C, Pereira GJ, Barbosa CM, Jurkiewicz A, Smaili SS, Bincoletto C (2014) Comparative study of autophagy inhibition by 3MA and CQ on Cytarabine-induced death of leukaemia cells. J Cancer Res Clin Oncol 140:909–920. https://doi.org/10.1007/s00432-014-1640-4CrossRefPubMed Palmeira dos Santos C, Pereira GJ, Barbosa CM, Jurkiewicz A, Smaili SS, Bincoletto C (2014) Comparative study of autophagy inhibition by 3MA and CQ on Cytarabine-induced death of leukaemia cells. J Cancer Res Clin Oncol 140:909–920. https://​doi.​org/​10.​1007/​s00432-014-1640-4CrossRefPubMed

go back to reference Gigli R, Pereira GJ, Antunes F et al (2016) The biphosphinic paladacycle complex induces melanoma cell death through lysosomal-mitochondrial axis modulation and impaired autophagy. Eur J Med Chem 107:245–254. https://doi.org/10.1016/j.ejmech.2015.11.008CrossRefPubMed Gigli R, Pereira GJ, Antunes F et al (2016) The biphosphinic paladacycle complex induces melanoma cell death through lysosomal-mitochondrial axis modulation and impaired autophagy. Eur J Med Chem 107:245–254. https://​doi.​org/​10.​1016/​j.​ejmech.​2015.​11.​008CrossRefPubMed

go back to reference Liang B, Kong D, Liu Y, Liang N, He M, Ma S, Liu X (2012) Autophagy inhibition plays the synergetic killing roles with radiation in the multi-drug resistant SKVCR ovarian cancer cells. Radiat Oncol 7:213. https://doi.org/10.1186/1748-717X-7-213CrossRefPubMedPubMedCentral Liang B, Kong D, Liu Y, Liang N, He M, Ma S, Liu X (2012) Autophagy inhibition plays the synergetic killing roles with radiation in the multi-drug resistant SKVCR ovarian cancer cells. Radiat Oncol 7:213. https://​doi.​org/​10.​1186/​1748-717X-7-213CrossRefPubMedPubMedCentral

go back to reference Chen Y, Li X, Guo L et al (2015) Combining radiation with autophagy inhibition enhances suppression of tumor growth and angiogenesis in esophageal cancer. Mol Med Rep 12:1645–1652. https://doi.org/10.3892/mmr.2015.3623CrossRefPubMedPubMedCentral Chen Y, Li X, Guo L et al (2015) Combining radiation with autophagy inhibition enhances suppression of tumor growth and angiogenesis in esophageal cancer. Mol Med Rep 12:1645–1652. https://​doi.​org/​10.​3892/​mmr.​2015.​3623CrossRefPubMedPubMedCentral

go back to reference Vakifahmetoglu-Norberg H, Xia HG, Yuan J (2015) Pharmacologic agents targeting autophagy. J Clin Invest 125:5–13. https://doi.org/10.1172/JCI73937CrossRefPubMedPubMedCentral Vakifahmetoglu-Norberg H, Xia HG, Yuan J (2015) Pharmacologic agents targeting autophagy. J Clin Invest 125:5–13. https://​doi.​org/​10.​1172/​JCI73937CrossRefPubMedPubMedCentral

go back to reference Pavlova NN, Thompson CB (2016) The emerging hallmarks of cancer metabolism. Cell Metab 23:27–47. https://doi.org/10.1016/j.cmet.2015.12.006CrossRefPubMedPubMedCentral Pavlova NN, Thompson CB (2016) The emerging hallmarks of cancer metabolism. Cell Metab 23:27–47. https://​doi.​org/​10.​1016/​j.​cmet.​2015.​12.​006CrossRefPubMedPubMedCentral

go back to reference Beloribi-Djefaflia S, Vasseur S, Guillaumond F (2016) Lipid metabolic reprogramming in cancer cells. Oncogenesis 5:e189. https://doi.org/10.1038/oncsis.2015.49CrossRefPubMedPubMedCentral Beloribi-Djefaflia S, Vasseur S, Guillaumond F (2016) Lipid metabolic reprogramming in cancer cells. Oncogenesis 5:e189. https://​doi.​org/​10.​1038/​oncsis.​2015.​49CrossRefPubMedPubMedCentral

go back to reference Renehan AG, Egger M, Minder C, O'Dwyer ST, Shalet SM, Zwahlen M (2005) IGF-I, IGF binding protein-3 and breast cancer risk: comparison of 3 meta-analyses. Int J Cancer 115:1006–1008. https://doi.org/10.1002/ijc.20975CrossRefPubMed Renehan AG, Egger M, Minder C, O'Dwyer ST, Shalet SM, Zwahlen M (2005) IGF-I, IGF binding protein-3 and breast cancer risk: comparison of 3 meta-analyses. Int J Cancer 115:1006–1008. https://​doi.​org/​10.​1002/​ijc.​20975CrossRefPubMed

go back to reference Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M (2004) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363:1346–1353. https://doi.org/10.1016/S0140-6736(04)16044-3CrossRef Renehan AG, Zwahlen M, Minder C, O'Dwyer ST, Shalet SM, Egger M (2004) Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 363:1346–1353. https://​doi.​org/​10.​1016/​S0140-6736(04)16044-3CrossRef

go back to reference Di Francesco A, Di Germanio C, Bernier M, de Cabo R (2018) A time to fast. Science 362:770–775. https://doi.org/10.1126/science.aau2095CrossRef Di Francesco A, Di Germanio C, Bernier M, de Cabo R (2018) A time to fast. Science 362:770–775. https://​doi.​org/​10.​1126/​science.​aau2095CrossRef

go back to reference Speakman JR, Mitchell SE (2011) Caloric restriction. Mol Asp Med 32:159–221. https://doi.org/10.1016/j.mam.2011.07.001CrossRef Speakman JR, Mitchell SE (2011) Caloric restriction. Mol Asp Med 32:159–221. https://​doi.​org/​10.​1016/​j.​mam.​2011.​07.​001CrossRef

go back to reference Hursting SD, Dunlap SM, Ford NA, Hursting MJ, Lashinger LM (2013) Calorie restriction and cancer prevention: a mechanistic perspective. Cancer Metab 1:10. https://doi.org/10.1186/2049-3002-1-10CrossRefPubMedPubMedCentral Hursting SD, Dunlap SM, Ford NA, Hursting MJ, Lashinger LM (2013) Calorie restriction and cancer prevention: a mechanistic perspective. Cancer Metab 1:10. https://​doi.​org/​10.​1186/​2049-3002-1-10CrossRefPubMedPubMedCentral

go back to reference Longo VD, Mattson MP (2013) Fasting: molecular mechanisms and clinical applications. Cell Metab 19:181–192. https://doi.org/10.1016/j.cmet.2013.12.008CrossRef Longo VD, Mattson MP (2013) Fasting: molecular mechanisms and clinical applications. Cell Metab 19:181–192. https://​doi.​org/​10.​1016/​j.​cmet.​2013.​12.​008CrossRef

go back to reference Imayama I, Ulrich CM, Alfano CM, Wang C, Xiao L, Wener MH, Campbell KL, Duggan C, Foster-Schubert KE, Kong A, Mason CE, Wang CY, Blackburn GL, Bain CE, Thompson HJ, McTiernan A (2012) Effects of a caloric restriction weight loss diet and exercise on inflammatory biomarkers in overweight/obese postmenopausal women: a randomized controlled trial. Cancer Res 72:2314–2326. https://doi.org/10.1158/0008-5472.CAN-11-3092CrossRefPubMedPubMedCentral Imayama I, Ulrich CM, Alfano CM, Wang C, Xiao L, Wener MH, Campbell KL, Duggan C, Foster-Schubert KE, Kong A, Mason CE, Wang CY, Blackburn GL, Bain CE, Thompson HJ, McTiernan A (2012) Effects of a caloric restriction weight loss diet and exercise on inflammatory biomarkers in overweight/obese postmenopausal women: a randomized controlled trial. Cancer Res 72:2314–2326. https://​doi.​org/​10.​1158/​0008-5472.​CAN-11-3092CrossRefPubMedPubMedCentral

go back to reference Berrigan D, Lavigne JA, Perkins SN, Nagy TR, Barrett JC, Hursting SD (2005) Phenotypic effects of calorie restriction and insulin-like growth factor-1 treatment on body composition and bone mineral density of C57BL/6 mice: implications for cancer prevention. In Vivo 19:667–674PubMed Berrigan D, Lavigne JA, Perkins SN, Nagy TR, Barrett JC, Hursting SD (2005) Phenotypic effects of calorie restriction and insulin-like growth factor-1 treatment on body composition and bone mineral density of C57BL/6 mice: implications for cancer prevention. In Vivo 19:667–674PubMed

go back to reference Bowers LW, Rossi EL, O'Flanagan CH, deGraffenried LA, Hursting SD (2015) The role of the insulin/IGF system in cancer: lessons learned from clinical trials and the energy balance-cancer link. Front Endocrinol (Lausanne) 6:77. https://doi.org/10.3389/fendo.2015.00077CrossRef Bowers LW, Rossi EL, O'Flanagan CH, deGraffenried LA, Hursting SD (2015) The role of the insulin/IGF system in cancer: lessons learned from clinical trials and the energy balance-cancer link. Front Endocrinol (Lausanne) 6:77. https://​doi.​org/​10.​3389/​fendo.​2015.​00077CrossRef

go back to reference Mukherjee P, Abate LE, Seyfried TN (2004) Antiangiogenic and proapoptotic effects of dietary restriction on experimental mouse and human brain tumors. Clin Cancer Res 10:5622–5629. https://doi.org/10.1158/1078-0432.CCR-04-0308CrossRefPubMed Mukherjee P, Abate LE, Seyfried TN (2004) Antiangiogenic and proapoptotic effects of dietary restriction on experimental mouse and human brain tumors. Clin Cancer Res 10:5622–5629. https://​doi.​org/​10.​1158/​1078-0432.​CCR-04-0308CrossRefPubMed

go back to reference Bianchi G, Martella R, Ravera S et al (2015) Fasting induces anti-Warburg effect that increases respiration but reduces ATP-synthesis to promote apoptosis in colon cancer models. Oncotarget 6:11806–11819. https://doi.org/10.18632/oncotarget.3688CrossRefPubMedPubMedCentral Bianchi G, Martella R, Ravera S et al (2015) Fasting induces anti-Warburg effect that increases respiration but reduces ATP-synthesis to promote apoptosis in colon cancer models. Oncotarget 6:11806–11819. https://​doi.​org/​10.​18632/​oncotarget.​3688CrossRefPubMedPubMedCentral

go back to reference Mattison JA, Colman RJ, Beasley TM, Allison DB, Kemnitz JW, Roth GS, Ingram DK, Weindruch R, de Cabo R, Anderson RM (2017) Caloric restriction improves health and survival of rhesus monkeys. Nat Commun 8:14063. https://doi.org/10.1038/ncomms14063CrossRefPubMedPubMedCentral Mattison JA, Colman RJ, Beasley TM, Allison DB, Kemnitz JW, Roth GS, Ingram DK, Weindruch R, de Cabo R, Anderson RM (2017) Caloric restriction improves health and survival of rhesus monkeys. Nat Commun 8:14063. https://​doi.​org/​10.​1038/​ncomms14063CrossRefPubMedPubMedCentral

go back to reference Lo Re O, Panebianco C, Porto S, Cervi C, Rappa F, di Biase S, Caraglia M, Pazienza V, Vinciguerra M (2018) Fasting inhibits hepatic stellate cells activation and potentiates anti-cancer activity of Sorafenib in hepatocellular cancer cells. J Cell Physiol 233:1202–1212. https://doi.org/10.1002/jcp.25987CrossRefPubMed Lo Re O, Panebianco C, Porto S, Cervi C, Rappa F, di Biase S, Caraglia M, Pazienza V, Vinciguerra M (2018) Fasting inhibits hepatic stellate cells activation and potentiates anti-cancer activity of Sorafenib in hepatocellular cancer cells. J Cell Physiol 233:1202–1212. https://​doi.​org/​10.​1002/​jcp.​25987CrossRefPubMed

go back to reference Caffa I, D'Agostino V, Damonte P et al (2015) Fasting potentiates the anticancer activity of tyrosine kinase inhibitors by strengthening MAPK signaling inhibition. Oncotarget 6:11820–11832. https://doi.org/10.18632/oncotarget.3689CrossRefPubMedPubMedCentral Caffa I, D'Agostino V, Damonte P et al (2015) Fasting potentiates the anticancer activity of tyrosine kinase inhibitors by strengthening MAPK signaling inhibition. Oncotarget 6:11820–11832. https://​doi.​org/​10.​18632/​oncotarget.​3689CrossRefPubMedPubMedCentral

go back to reference Caccialanza R, Cereda E, De Lorenzo F, Farina G, Pedrazzoli P, AIOM-SINPE-FAVO Working Group (2018) To fast, or not to fast before chemotherapy, that is the question. BMC Cancer 18:337. Published 2018 Mar 27. https://doi.org/10.1186/s12885-018-4245-5CrossRefPubMedPubMedCentral Caccialanza R, Cereda E, De Lorenzo F, Farina G, Pedrazzoli P, AIOM-SINPE-FAVO Working Group (2018) To fast, or not to fast before chemotherapy, that is the question. BMC Cancer 18:337. Published 2018 Mar 27. https://​doi.​org/​10.​1186/​s12885-018-4245-5CrossRefPubMedPubMedCentral

go back to reference Sancar A, Lindsey-Boltz LA, Gaddameedhi S, Selby CP, Ye R, Chiou YY, Kemp MG, Hu J, Lee JH, Ozturk N (2015) Circadian clock, cancer, and chemotherapy. Biochemistry 54:110–123. https://doi.org/10.1021/bi5007354CrossRefPubMed Sancar A, Lindsey-Boltz LA, Gaddameedhi S, Selby CP, Ye R, Chiou YY, Kemp MG, Hu J, Lee JH, Ozturk N (2015) Circadian clock, cancer, and chemotherapy. Biochemistry 54:110–123. https://​doi.​org/​10.​1021/​bi5007354CrossRefPubMed

go back to reference Safdie F, Brandhorst S, Wei M, Wang W, Lee C, Hwang S, Conti PS, Chen TC, Longo VD (2012) Fasting enhances the response of glioma to chemo- and radiotherapy. PLoS One 7:e44603. https://doi.org/10.1371/journal.pone.0044603CrossRefPubMedPubMedCentral Safdie F, Brandhorst S, Wei M, Wang W, Lee C, Hwang S, Conti PS, Chen TC, Longo VD (2012) Fasting enhances the response of glioma to chemo- and radiotherapy. PLoS One 7:e44603. https://​doi.​org/​10.​1371/​journal.​pone.​0044603CrossRefPubMedPubMedCentral

go back to reference Raffaghello L, Lee C, Safdie FM, Wei M, Madia F, Bianchi G, Longo VD (2008) Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy. Proc Natl Acad Sci U S A 105:8215–8220. https://doi.org/10.1073/pnas.0708100105CrossRefPubMedPubMedCentral Raffaghello L, Lee C, Safdie FM, Wei M, Madia F, Bianchi G, Longo VD (2008) Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy. Proc Natl Acad Sci U S A 105:8215–8220. https://​doi.​org/​10.​1073/​pnas.​0708100105CrossRefPubMedPubMedCentral

go back to reference Cheng CW, Adams GB, Perin L, Wei M, Zhou X, Lam BS, da Sacco S, Mirisola M, Quinn DI, Dorff TB, Kopchick JJ, Longo VD (2014) Prolonged fasting reduces IGF-1/PKA to promote hematopoietic-stem-cell-based regeneration and reverse immunosuppression. Cell Stem Cell 14:810–823. https://doi.org/10.1016/j.stem.2014.04.014CrossRefPubMedPubMedCentral Cheng CW, Adams GB, Perin L, Wei M, Zhou X, Lam BS, da Sacco S, Mirisola M, Quinn DI, Dorff TB, Kopchick JJ, Longo VD (2014) Prolonged fasting reduces IGF-1/PKA to promote hematopoietic-stem-cell-based regeneration and reverse immunosuppression. Cell Stem Cell 14:810–823. https://​doi.​org/​10.​1016/​j.​stem.​2014.​04.​014CrossRefPubMedPubMedCentral

go back to reference Brandhorst S, Choi IY, Wei M, Cheng CW, Sedrakyan S, Navarrete G, Dubeau L, Yap LP, Park R, Vinciguerra M, di Biase S, Mirzaei H, Mirisola MG, Childress P, Ji L, Groshen S, Penna F, Odetti P, Perin L, Conti PS, Ikeno Y, Kennedy BK, Cohen P, Morgan TE, Dorff TB, Longo VD (2015) A periodic diet that mimics fasting promotes multi-system regeneration, enhanced cognitive performance, and healthspan. Cell Metab 22:86–99. https://doi.org/10.1016/j.cmet.2015.05.012CrossRefPubMedPubMedCentral Brandhorst S, Choi IY, Wei M, Cheng CW, Sedrakyan S, Navarrete G, Dubeau L, Yap LP, Park R, Vinciguerra M, di Biase S, Mirzaei H, Mirisola MG, Childress P, Ji L, Groshen S, Penna F, Odetti P, Perin L, Conti PS, Ikeno Y, Kennedy BK, Cohen P, Morgan TE, Dorff TB, Longo VD (2015) A periodic diet that mimics fasting promotes multi-system regeneration, enhanced cognitive performance, and healthspan. Cell Metab 22:86–99. https://​doi.​org/​10.​1016/​j.​cmet.​2015.​05.​012CrossRefPubMedPubMedCentral

go back to reference Pietrocola F, Pol J, Vacchelli E et al (2016) Caloric restriction mimetics enhance anticancer immunosurveillance. Cancer Cell 30:147–160. https://doi.org/10.1016/j.ccell.2016.05.016CrossRefPubMedPubMedCentral Pietrocola F, Pol J, Vacchelli E et al (2016) Caloric restriction mimetics enhance anticancer immunosurveillance. Cancer Cell 30:147–160. https://​doi.​org/​10.​1016/​j.​ccell.​2016.​05.​016CrossRefPubMedPubMedCentral

go back to reference Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, Nadon NL, Wilkinson JE, Frenkel K, Carter CS, Pahor M, Javors MA, Fernandez E, Miller RA (2009) Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460:392–395. https://doi.org/10.1038/nature08221CrossRefPubMedPubMedCentral Harrison DE, Strong R, Sharp ZD, Nelson JF, Astle CM, Flurkey K, Nadon NL, Wilkinson JE, Frenkel K, Carter CS, Pahor M, Javors MA, Fernandez E, Miller RA (2009) Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature 460:392–395. https://​doi.​org/​10.​1038/​nature08221CrossRefPubMedPubMedCentral

go back to reference Pollak MN (2012) Investigating metformin for cancer prevention and treatment: the end of the beginning. Cancer Discov 2:778–790. https://doi.org/10.1158/2159-8290.CD-12-0263CrossRef Pollak MN (2012) Investigating metformin for cancer prevention and treatment: the end of the beginning. Cancer Discov 2:778–790. https://​doi.​org/​10.​1158/​2159-8290.​CD-12-0263CrossRef

go back to reference Caffa I, Spagnolo V, Vernieri C, Valdemarin F, Becherini P, Wei M, Brandhorst S, Zucal C, Driehuis E, Ferrando L, Piacente F, Tagliafico A, Cilli M, Mastracci L, Vellone VG, Piazza S, Cremonini AL, Gradaschi R, Mantero C, Passalacqua M, Ballestrero A, Zoppoli G, Cea M, Arrighi A, Odetti P, Monacelli F, Salvadori G, Cortellino S, Clevers H, de Braud F, Sukkar SG, Provenzani A, Longo VD, Nencioni A (2020) Fasting-mimicking diet and hormone therapy induce breast cancer regression. Nature 583:620–624. https://doi.org/10.1038/s41586-020-2502-7CrossRefPubMedPubMedCentral Caffa I, Spagnolo V, Vernieri C, Valdemarin F, Becherini P, Wei M, Brandhorst S, Zucal C, Driehuis E, Ferrando L, Piacente F, Tagliafico A, Cilli M, Mastracci L, Vellone VG, Piazza S, Cremonini AL, Gradaschi R, Mantero C, Passalacqua M, Ballestrero A, Zoppoli G, Cea M, Arrighi A, Odetti P, Monacelli F, Salvadori G, Cortellino S, Clevers H, de Braud F, Sukkar SG, Provenzani A, Longo VD, Nencioni A (2020) Fasting-mimicking diet and hormone therapy induce breast cancer regression. Nature 583:620–624. https://​doi.​org/​10.​1038/​s41586-020-2502-7CrossRefPubMedPubMedCentral

go back to reference Ho VW, Leung K, Hsu A, Luk B, Lai J, Shen SY, Minchinton AI, Waterhouse D, Bally MB, Lin W, Nelson BH, Sly LM, Krystal G (2011) A low carbohydrate, high protein diet slows tumor growth and prevents cancer initiation. Cancer Res 71:4484–4493. https://doi.org/10.1158/0008-5472.CAN-10-3973CrossRefPubMed Ho VW, Leung K, Hsu A, Luk B, Lai J, Shen SY, Minchinton AI, Waterhouse D, Bally MB, Lin W, Nelson BH, Sly LM, Krystal G (2011) A low carbohydrate, high protein diet slows tumor growth and prevents cancer initiation. Cancer Res 71:4484–4493. https://​doi.​org/​10.​1158/​0008-5472.​CAN-10-3973CrossRefPubMed

go back to reference Caso J, Masko EM, Ii JA et al (2013) The effect of carbohydrate restriction on prostate cancer tumor growth in a castrate mouse xenograft model. Prostate 73:449–454. https://doi.org/10.1002/pros.22586CrossRefPubMed Caso J, Masko EM, Ii JA et al (2013) The effect of carbohydrate restriction on prostate cancer tumor growth in a castrate mouse xenograft model. Prostate 73:449–454. https://​doi.​org/​10.​1002/​pros.​22586CrossRefPubMed

go back to reference Stafford P, Abdelwahab MG, Kim DY, Preul MC, Rho JM, Scheck AC (2010) The ketogenic diet reverses gene expression patterns and reduces reactive oxygen species levels when used as an adjuvant therapy for glioma. Nutr Metab (Lond) 7:74. https://doi.org/10.1186/1743-7075-7-74CrossRef Stafford P, Abdelwahab MG, Kim DY, Preul MC, Rho JM, Scheck AC (2010) The ketogenic diet reverses gene expression patterns and reduces reactive oxygen species levels when used as an adjuvant therapy for glioma. Nutr Metab (Lond) 7:74. https://​doi.​org/​10.​1186/​1743-7075-7-74CrossRef

go back to reference Klement RJ (2018) Fasting, fats, and physics: combining ketogenic and radiation therapy against cancer. Complement Med Res 25:102–113. https://doi.org/10.1159/000484045CrossRefPubMed Klement RJ (2018) Fasting, fats, and physics: combining ketogenic and radiation therapy against cancer. Complement Med Res 25:102–113. https://​doi.​org/​10.​1159/​000484045CrossRefPubMed

go back to reference Most J, Tosti V, Redman LM, Fontana L (2016) Calorie restriction in humans: an update. Ageing Res Rev 39:36–45. https://doi.org/10.1016/j.arr.2016.08.005CrossRefPubMedPubMedCentral Most J, Tosti V, Redman LM, Fontana L (2016) Calorie restriction in humans: an update. Ageing Res Rev 39:36–45. https://​doi.​org/​10.​1016/​j.​arr.​2016.​08.​005CrossRefPubMedPubMedCentral

go back to reference Saleh AD, Simone BA, Palazzo J, Savage JE, Sano Y, Dan T, Jin L, Champ C, Zhao S, Lim M, Sotgia F, Camphausen K, Pestell R, Mitchell J, Lisanti M, Simone NL (2013) Caloric restriction augments radiation efficacy in breast cancer. Cell Cycle 12:1955–1963. https://doi.org/10.4161/cc.25016CrossRefPubMedPubMedCentral Saleh AD, Simone BA, Palazzo J, Savage JE, Sano Y, Dan T, Jin L, Champ C, Zhao S, Lim M, Sotgia F, Camphausen K, Pestell R, Mitchell J, Lisanti M, Simone NL (2013) Caloric restriction augments radiation efficacy in breast cancer. Cell Cycle 12:1955–1963. https://​doi.​org/​10.​4161/​cc.​25016CrossRefPubMedPubMedCentral

go back to reference Safdie FM, Dorff T, Quinn D et al (2009) Fasting and cancer treatment in humans: a case series report. Aging (Albany NY) 1:988–1007. https://doi.org/10.18632/aging.100114CrossRef Safdie FM, Dorff T, Quinn D et al (2009) Fasting and cancer treatment in humans: a case series report. Aging (Albany NY) 1:988–1007. https://​doi.​org/​10.​18632/​aging.​100114CrossRef

go back to reference Badar T, Ismail A, Alshanqqeeti A (2014) Safety and feasability of Muslim fasting while receiving chemotherapy. IOSR J Pharm 4:15–20. https://doi.org/10.9790/3013-0401015-20 Badar T, Ismail A, Alshanqqeeti A (2014) Safety and feasability of Muslim fasting while receiving chemotherapy. IOSR J Pharm 4:15–20. https://​doi.​org/​10.​9790/​3013-0401015-20

go back to reference Dorff TB, Groshen S, Garcia A, Shah M, Tsao-Wei D, Pham H, Cheng CW, Brandhorst S, Cohen P, Wei M, Longo V, Quinn DI (2016) Safety and feasibility of fasting in combination with platinum-based chemotherapy. BMC Cancer 16:360. https://doi.org/10.1186/s12885-016-2370-6CrossRefPubMedPubMedCentral Dorff TB, Groshen S, Garcia A, Shah M, Tsao-Wei D, Pham H, Cheng CW, Brandhorst S, Cohen P, Wei M, Longo V, Quinn DI (2016) Safety and feasibility of fasting in combination with platinum-based chemotherapy. BMC Cancer 16:360. https://​doi.​org/​10.​1186/​s12885-016-2370-6CrossRefPubMedPubMedCentral

go back to reference Bauersfeld SP, Kessler CS, Wischnewsky M, Jaensch A, Steckhan N, Stange R, Kunz B, Brückner B, Sehouli J, Michalsen A (2018) The effects of short-term fasting on quality of life and tolerance to chemotherapy in patients with breast and ovarian cancer: a randomized cross-over pilot study. BMC Cancer 18:476. https://doi.org/10.1186/s12885-018-4353-2CrossRefPubMedPubMedCentral Bauersfeld SP, Kessler CS, Wischnewsky M, Jaensch A, Steckhan N, Stange R, Kunz B, Brückner B, Sehouli J, Michalsen A (2018) The effects of short-term fasting on quality of life and tolerance to chemotherapy in patients with breast and ovarian cancer: a randomized cross-over pilot study. BMC Cancer 18:476. https://​doi.​org/​10.​1186/​s12885-018-4353-2CrossRefPubMedPubMedCentral

go back to reference de Groot S, Vreeswijk MP, Welters MJ et al (2015) The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study. BMC Cancer 15:652. https://doi.org/10.1186/s12885-015-1663-5CrossRefPubMedPubMedCentral de Groot S, Vreeswijk MP, Welters MJ et al (2015) The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study. BMC Cancer 15:652. https://​doi.​org/​10.​1186/​s12885-015-1663-5CrossRefPubMedPubMedCentral

go back to reference Tan-Shalaby JL, Carrick J, Edinger K, Genovese D, Liman AD, Passero VA, Shah RB (2016) Modified Atkins diet in advanced malignancies - final results of a safety and feasibility trial within the Veterans Affairs Pittsburgh Healthcare System. Nutr Metab (Lond) 13:52. https://doi.org/10.1186/s12986-016-0113-yCrossRef Tan-Shalaby JL, Carrick J, Edinger K, Genovese D, Liman AD, Passero VA, Shah RB (2016) Modified Atkins diet in advanced malignancies - final results of a safety and feasibility trial within the Veterans Affairs Pittsburgh Healthcare System. Nutr Metab (Lond) 13:52. https://​doi.​org/​10.​1186/​s12986-016-0113-yCrossRef

go back to reference Rieger J, Bähr O, Maurer GD et al (2014) ERGO: a pilot study of ketogenic diet in recurrent glioblastoma. Int J Oncol 44:1843–1852. https://doi.org/10.3892/ijo.2014.2382CrossRefPubMedPubMedCentral Rieger J, Bähr O, Maurer GD et al (2014) ERGO: a pilot study of ketogenic diet in recurrent glioblastoma. Int J Oncol 44:1843–1852. https://​doi.​org/​10.​3892/​ijo.​2014.​2382CrossRefPubMedPubMedCentral

go back to reference Kerndt PR, Naughton JL, Driscoll CE, Loxterkamp DA (1982) Fasting: the history, pathophysiology and complications. West J Med 137:379–399PubMedPubMedCentral Kerndt PR, Naughton JL, Driscoll CE, Loxterkamp DA (1982) Fasting: the history, pathophysiology and complications. West J Med 137:379–399PubMedPubMedCentral

go back to reference de Groot S, Pijl H, van der Hoeven JJM, Kroep JR (2019) Effects of short-term fasting on cancer treatment. J Exp Clin Cancer Res 38:209. https://doi.org/10.1186/s13046-019-1189-9CrossRefPubMedPubMedCentral de Groot S, Pijl H, van der Hoeven JJM, Kroep JR (2019) Effects of short-term fasting on cancer treatment. J Exp Clin Cancer Res 38:209. https://​doi.​org/​10.​1186/​s13046-019-1189-9CrossRefPubMedPubMedCentral

go back to reference Castejón M, Plaza A, Martinez-Romero J, Fernandez-Marcos PJ, Cabo R, Diaz-Ruiz A (2020) Energy restriction and colorectal cancer: a call for additional research. Nutrients 12:114. https://doi.org/10.3390/nu12010114CrossRefPubMedCentral Castejón M, Plaza A, Martinez-Romero J, Fernandez-Marcos PJ, Cabo R, Diaz-Ruiz A (2020) Energy restriction and colorectal cancer: a call for additional research. Nutrients 12:114. https://​doi.​org/​10.​3390/​nu12010114CrossRefPubMedCentral